Status: Recruiting
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
The aim of the study is to evaluate the use of Granulocyte Colony Stimulating Factor (GCSF) on the clinical and biochemical outcome of type 3 biliary atresia post kasai.
Participants needed: 40
Trial details
Age: 20-1Biological sex: AllType: InterventionalSponsor: National Liver Institute, EgyptUpdated: Dec 11, 2024Locations: 1
Eligibility criteria
Infants with initial diagnosis of biliary atresia with biliary atresia score > 2...
Major cardiac, renal, pulmonary, neurological malformations or illnesses. [+5]